NGMA-6. Quantitative MGMT Promoter Methylation Index Indicates Non-Linear, Prognostic Effect in Glioblastoma

BACKGROUND: Epigenetic inhibition of the O6-methylguanine-DNA-methyltransferase (MGMT) gene has emerged as a clinically relevant prognostic marker in glioblastoma (GBM). Methylation of the MGMT promoter has been shown to increase chemotherapy efficacy. While traditionally reported as a binary marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, David, Ravi, Akshay, Rodriguez, Eduardo, Chang, Susan, Bush, Nancy, Taylor, Jennie, Clarke, Jennifer, Solomon, David, Scheffler, Aaron, Witte, John, Okada, Hideho, Berger, Mitchel, Chehab, Farid, Butowski, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255458/
http://dx.doi.org/10.1093/noajnl/vdab070.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255458/
http://dx.doi.org/10.1093/noajnl/vdab070.021

Ejemplares similares